Gilead Sciences Aktie

Kaufen

Verkaufen

Handeln Handeln

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

99,00 EUR +0,94 EUR +0,96 %

29.07.2025

BMN

114,39 USD +0,15 USD +0,13 %

nachbörslich00:17:31

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.121,68 Mrd. EUR

KGV241,49Div. Rendite3,33%

WKN885823

ISINUS3755581036

SymbolGILD

Gilead Sciences Aktien News

Sortieren:Datum Meistgelesen

10.12.24BenzingaWhat Analysts Are Saying About Gilead Sciences Stock

10.12.24ZacksThe Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group

09.12.24ZacksTop Stock Reports for Eli Lilly, AbbVie & Gilead Sciences

04.12.24ZacksGilead Collaborates With German Biotech Tubulis for Solid Tumor ADC

03.12.24BenzingaLooking At Gilead Sciences's Recent Unusual Options Activity

03.12.24ZacksIs Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic?

29.11.24ZacksGilead Stock Surges 44.2% in 6 Months: Time to Buy or Sell?

28.11.24ZacksInvestors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

25.11.24BenzingaPrice Over Earnings Overview: Gilead Sciences

18.11.24Benzinga26 Analysts Assess Gilead Sciences: What You Need To Know

15.11.24BenzingaGilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease

14.11.24ZacksBrokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet

14.11.24ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

07.11.24BenzingaHIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook

07.11.24ZacksGilead Beats on Q3 Earnings and Sales, Raises Annual Outlook

07.11.24MotleyFoolGilead Sciences (GILD) Q3 2024 Earnings Call Transcript

07.11.24ZacksGilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say

06.11.24ZacksGilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates

06.11.24BenzingaHere's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today

05.11.24BenzingaGilead Sciences's Earnings: A Preview

04.11.24ZacksGilead Science to Report Q3 Earnings: What's in the Cards?

01.11.24ZacksAhead of Gilead (GILD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

31.10.24ZacksGilead Sciences (GILD) Gains As Market Dips: What You Should Know

31.10.24ZacksGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

30.10.24ZacksEarnings Preview: Gilead Sciences (GILD) Q3 Earnings Expected to Decline

29.10.24ZacksGilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why

24.10.24ZacksWhy Gilead Sciences (GILD) Dipped More Than Broader Market Today

21.10.24ZacksGilead, MRK Report Data From Investigational Combination Study for HIV

21.10.24BenzingaGilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks

21.10.24BenzingaPeering Into Gilead Sciences's Recent Short Interest

21.10.24BenzingaEvaluating Gilead Sciences: Insights From 15 Financial Analysts

18.10.24BenzingaAfter Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment

17.10.24BenzingaHere's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today

17.10.24BenzingaThis Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

17.10.24ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

16.10.24ZacksGilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts

09.10.24ZacksGilead Sciences (GILD) Increases Yet Falls Behind Market: What Investors Need to Know

04.10.24BenzingaPeeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights

03.10.24ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

03.10.24New York TimesGilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.